SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-010450
Filing Date
2020-06-03
Accepted
2020-06-03 12:33:38
Documents
9
Period of Report
2020-04-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 83499
2 ex10-1.htm EX-10.1 71880
3 ex10-2.htm EX-10.2 52655
4 ex10-3.htm EX-10.3 77741
5 ex10-4.htm EX-10.4 52680
6 ex10-5.htm EX-10.5 80671
7 ex10-6.htm EX-10.6 179443
8 ex10-7.htm EX-10.7 142976
9 ex10-6_001.jpg GRAPHIC 1992
  Complete submission text file 0001493152-20-010450.txt   746087
Mailing Address 555 MADISON AVENUE 5TH FLOOR SUITE 506 NEW YORK NY 10022
Business Address 555 MADISON AVENUE 5TH FLOOR SUITE 506 NEW YORK NY 10022 917-796-9926
TAURIGA SCIENCES, INC. (Filer) CIK: 0001142790 (see all company filings)

IRS No.: 651102237 | State of Incorp.: FL | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-53723 | Film No.: 20939438
SIC: 2833 Medicinal Chemicals & Botanical Products